Your browser doesn't support javascript.
loading
Correlation Between Early Endpoints and Overall Survival in Non-Small-Cell Lung Cancer: A Trial-Level Meta-Analysis.
Shameer, Khader; Zhang, Youyi; Jackson, Dan; Rhodes, Kirsty; Neelufer, Imran Khan A; Nampally, Sreenath; Prokop, Andrzej; Hutchison, Emmette; Ye, Jiabu; Malkov, Vladislav A; Liu, Feng; Sabin, Antony; Weatherall, Jim; Duran, Cristina; Iacona, Renee Bailey; Khan, Faisal M; Mukhopadhyay, Pralay.
Affiliation
  • Shameer K; Data Science and Artificial Intelligence, BioPharmaceuticals Research and Development (R&D), AstraZeneca, Gaithersburg, MD, United States.
  • Zhang Y; Data Science and Artificial Intelligence, BioPharmaceuticals Research and Development (R&D), AstraZeneca, Gaithersburg, MD, United States.
  • Jackson D; Oncology Biometrics, Oncology Research and Development, AstraZeneca, Cambridge, United Kingdom.
  • Rhodes K; Oncology Biometrics, Oncology Research and Development, AstraZeneca, Cambridge, United Kingdom.
  • Neelufer IKA; Data Science and Artificial Intelligence, BioPharmaceuticals Research and Development, AstraZeneca, Macclesfield, United Kingdom.
  • Nampally S; Data Science and Artificial Intelligence, BioPharmaceuticals Research and Development (R&D), AstraZeneca, Gaithersburg, MD, United States.
  • Prokop A; Oncology Biometrics, Oncology Research and Development, AstraZeneca, Warsaw, Poland.
  • Hutchison E; Digital Health, Oncology Research and Development, AstraZeneca, Cambridge, United Kingdom.
  • Ye J; Oncology Biometrics, Oncology R&D, AstraZeneca, Gaithersburg, MD, United States.
  • Malkov VA; Data Science and Artificial Intelligence, BioPharmaceuticals Research and Development (R&D), AstraZeneca, Gaithersburg, MD, United States.
  • Liu F; Oncology Biometrics, Oncology R&D, AstraZeneca, Gaithersburg, MD, United States.
  • Sabin A; Oncology Biometrics, Oncology Research and Development, AstraZeneca, Cambridge, United Kingdom.
  • Weatherall J; Data Science and Artificial Intelligence, BioPharmaceuticals Research and Development, AstraZeneca, Macclesfield, United Kingdom.
  • Duran C; Digital Health, Oncology Research and Development, AstraZeneca, Cambridge, United Kingdom.
  • Iacona RB; Oncology Biometrics, Oncology R&D, AstraZeneca, Gaithersburg, MD, United States.
  • Khan FM; Data Science and Artificial Intelligence, BioPharmaceuticals Research and Development (R&D), AstraZeneca, Gaithersburg, MD, United States.
  • Mukhopadhyay P; Oncology Biometrics, Oncology R&D, AstraZeneca, Gaithersburg, MD, United States.
Front Oncol ; 11: 672916, 2021.
Article in En | MEDLINE | ID: mdl-34381708
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Prognostic_studies / Systematic_reviews Language: En Journal: Front Oncol Year: 2021 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Prognostic_studies / Systematic_reviews Language: En Journal: Front Oncol Year: 2021 Document type: Article Affiliation country: Country of publication: